SCHEMBL22029368

SCHEMBL22029368

COC(=O)CCNC(=O)c1cnc(NS(=O)(=O)c2ccc(Oc3ccc(CCCCCCCCCCCCCC(=O)O)cc3)cc2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.45
▸ CCR9 P51686 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ TBXAS1 P24557 2/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ EGLN2 Q96KS0 1/20 0.39
▸ EGLN1 Q9GZT9 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ PTPN11 Q06124 1/20 0.38
▸ PTPN22 Q9Y2R2 1/20 0.38
▸ PLAAT3 P53816 1/20 0.38
▸ PLAAT5 Q96KN8 1/20 0.38
▸ PLAAT2 Q9NWW9 1/20 0.38
▸ PLAAT4 Q9UL19 1/20 0.38
▸ NR3C1 P04150 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257938 0.91 TDP1 (0.44) TDP1CCR9MEN1KMT2AAKT1
SCHEMBL22029350 0.90 TDP1 (0.41) TDP1CCR9TBXAS1TBXA2RMEN1
SCHEMBL22080450 0.86 ALDH1A1 (0.39) TDP1POLBNPC1RAB9AMEN1
SCHEMBL22080331 0.83 TDP1 (0.38) TDP1POLBTBXAS1TBXA2RNPC1
SCHEMBL24257979 0.82 MEN1 (0.37) TDP1POLBNPC1RAB9AMEN1
SCHEMBL22105974 0.82 TDP1 (0.37) TDP1CCR9TBXAS1TBXA2RMEN1
SCHEMBL24257968 0.81 TDP1 (0.42) TDP1TBXAS1HDAC6EGLN2EGLN1
SCHEMBL24257966 0.81 TDP1 (0.50) TDP1NPC1RAB9AHDAC6ALDH1A1
SCHEMBL24257988 0.78 NPC1 (0.40) TDP1NPC1RAB9AMEN1KMT2A
SCHEMBL22029401 0.78 NPC1 (0.40) TDP1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed
EP-3893934-A1 INSULIN CONJUGATES SANOFI (FR) 2021-10-20 — — EP disclosed
EP-3894391-A1 PEPTIDE BINDER SANOFI (FR) 2021-10-20 — — EP disclosed
WO-2020120479-A1 PEPTIDE BINDER SANOFI (FR) 2020-06-18 — — WO disclosed
WO-2020120463-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-18 — — WO disclosed
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885CCR9 3641/4885POLB 4107/4885
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885CCR9 3641/4885POLB 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback